O19 Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology"
DOI: 10.1093/rheumatology/keab246.018
Abstract: Background/Aims BILAG-2004 index is required to prescribe and monitor biologics in SLE. It is more comprehensive and responsive than the SLEDAI and widely used in clinical trials. However, it may be time-consuming and does require… read more here.
Keywords: bilag 2004; none; new tool; easy bilag ... See more keywords
POS0106 BILAG-2004 LDA AND BST LDA ARE VALID TREAT TO TARGET IN SLE
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.10
Abstract: Low disease activity state has been defined using SLEDAI and used as treatment target in SLE. However, there has not been any such definition using BILAG-2004 index (BILAG-2004).This study was to determine if low disease… read more here.
Keywords: bilag 2004; none declared; activity; bilag ... See more keywords
OP0134 NOVEL INTERFERON GENE EXPRESSION SCORES PREDICT REFRACTORY SEVERE CUTANEOUS DISEASE FOLLOWING RITUXIMAB THERAPY IN SLE
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.1098
Abstract: We developed and validated two continuous interferon-stimulated gene (ISG) expression scores (IFN-Score-A and IFN-Score-B) that predict clinical outcomes in SLE. IFN-Score-A includes ISGs typically present in a global interferon signature while IFN-Score-B includes additional ISGs… read more here.
Keywords: ifn score; none declared; bilag; disease ... See more keywords